Tighter oversight of manufacturers pricing policies and the competitive environment Its unseemly (polite word choice) that the CEO of Lilly, Dave Ricks, is able to rake in total compensation of $114 million in 2024 while at the same time acknowledging that the price his company charges for Zepbound is too high. Unseemly, because his payday was fueled by Lilly making more than $10 billion in profit from GLP-1s in 2024 alone
The GI-MAP Comprehensive Stool Analysis with PCR quantifies Candida DNA directly in the stool and simultaneously profiles the entire gut microbiome, revealing dysbiosis patterns and beneficial bacterial deficiencies that allowed Candida to proliferate
The most commonly reported are gastrointestinal symptoms like nausea, vomiting and diarrhoea
The figures differ by 0.4 g/mol
Appl Sci 13(9):5686 Biernasiuk A, Baj T, Malm A (2022) Clove essential oil and its main constituent, eugenol, as potential natural antifungals against Candida spp